#ASCO14 - Poster: Establishing a neo-adjuvant platform for developing targeted agents: Androgen deprivation therapy prior to prostatectomy for patients with intermediate- and high-risk prostate cancer

CHICAGO, IL USA (UroToday.com) - Presented by K. A. Touijer, Y. Chen, B. S. Carver, J. A. Coleman, V. P. Laudone, M. Hullings, S. S. Ehrlich, M. DeNunzio, V. E. Reuter, J. A. Eastham, D. C. Danila, S. F. Slovin, M. J. Morris, Y. Chen, P. T. Scardino, H. I. Scher, and D. E. Rathkopf at the American Society of Clinical Oncology (ASCO) 50th Annual Meeting - May 30 - June 3, 2014 - Chicago, Illinois USA

asco 2014 touijer poster thumb

Click HERE to listen to an exclusive interview with Karim A. Touijer, MD, one of the authors of the study

Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY USA